Ira Weisberg
Corporate Officer/Principal chez ENDONOVO THERAPEUTICS, INC.
Profil
Ira Weisberg is currently the Chief Executive Officer & President at Sofpulse, Inc. and the President-Medical Division at Endonovo Therapeutics, Inc. He previously worked as the President & Chief Executive Officer at AlphaVax, Inc., the Chief Executive Officer at Amherst Pharmaceuticals LLC, and as the Vice President-Commercial Operations at Neurotrope, Inc. and Synaptogenix, Inc. He completed his undergraduate degree at St. John's University.
Postes actifs de Ira Weisberg
| Sociétés | Poste | Début |
|---|---|---|
| ENDONOVO THERAPEUTICS, INC. | Corporate Officer/Principal | 30/11/2022 |
Sofpulse, Inc.
 Sofpulse, Inc. Medical SpecialtiesHealth Technology Sofpulse, Inc. develops and commercializes medical devices. The CEO of the American company is Ira Weisberg. | Directeur Général | - |
Anciens postes connus de Ira Weisberg
| Sociétés | Poste | Fin |
|---|---|---|
Amherst Pharmaceuticals LLC
 Amherst Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Amherst Pharmaceuticals LLC is a private company that manufactures pharmaceutical products. The company is based in Basking Ridge, NJ. | Directeur Général | - |
| SYNAPTOGENIX, INC. | Corporate Officer/Principal | - |
AlphaVax, Inc.
 AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | Directeur Général | - |
| NEUROTROPE, INC. | Corporate Officer/Principal | - |
Formation de Ira Weisberg
| St. John's University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ENDONOVO THERAPEUTICS, INC. | Health Technology |
| SYNAPTOGENIX, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Neurotrope, Inc.
 Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY. | Health Technology |
AlphaVax, Inc.
AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | Health Technology |
Amherst Pharmaceuticals LLC
Amherst Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Amherst Pharmaceuticals LLC is a private company that manufactures pharmaceutical products. The company is based in Basking Ridge, NJ. | Health Technology |
Sofpulse, Inc.
Sofpulse, Inc. Medical SpecialtiesHealth Technology Sofpulse, Inc. develops and commercializes medical devices. The CEO of the American company is Ira Weisberg. | Health Technology |